National Health Investors posted Q2 net income attributable to common stockholders of $55.58 million, up 45.6%, with diluted EPS rising to $1.15.
Revenue climbed to $121.32 million from higher resident fees and services, while rental income edged up to $71.39 million.
NAREIT FFO per diluted share held at $1.19, while normalized FAD increased to $61.62 million.
The company completed sales of four properties for $91.8 million in net proceeds, booking $22 million in gains on real estate dispositions.
It closed the NHC leased portfolio sale on July 1 for $560 million, expecting a roughly $541.6 million gain; the quarterly dividend was raised to $0.94.